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Purpose. This study was aimed at evaluating sirtuin 4 (Sirt4) levels in obese individuals, in relation to their adherence to the
Mediterranean diet (MD), a healthy dietary pattern characterized by high antioxidant capacity, and markers of visceral fat
storage. Subjects/Methods. Forty-three obese patients (44% males; BMI: 36.7–58.8 kg/m2) were consecutively included.
PREvención con DIeta MEDiterránea (PREDIMED) and the 7-day food records were used to assess the adherence to MD and
dietary pattern, respectively. Visceral adiposity index (VAI) was calculated. Sirt4 levels were detected by ELISA method. Results.
The majority of the obese participants (62.8%) had an average adherence to MD. Compared with average adherers, low adherers
had higher BMI, energy intake, and percentage of energy from lipids, mainly saturated fat and polyunsaturated fatty acids
(PUFA), and lower Sirt4 levels. After adjusting for BMI, Sirt4 levels remained negatively correlated with VAI. After adjusting for
total energy intake, Sirt4 levels remained negatively associated with PREDIMED and consumption of n-3 PUFA, vitamins C and
E. The threshold value of PREDIMED predicting the lowest decrease in Sirt4 levels was found at a score of 6. Conclusions. Less
reduced Sirt4 levels in obese patients adhering to MD suggest a further aspect of the antioxidant advantage of MD.
1. Introduction
Diet, a modiﬁable environmental factor, is a mainstay in the
management of obese individuals. Mediterranean diet (MD)
is a healthy dietary pattern based on a common dietary
pattern of the Mediterranean countries [1]. In particular,
the MD is characterized by very low amounts of saturated
fatty acid (SFA) and a high consumption of polyunsaturated
fatty acid (PUFA) and micronutrients, including dietary
vitamins and minerals, commonly reported to increase the
plasma antioxidant capacity [2]. In addition, the quantity
and quality of dietary lipids are known to have an impact
on excess storage of lipid as triglycerides (TG) in both
adipose tissue and in nonadipose tissue sites, such as the
liver [3], which can have subsequent deleterious metabolic
eﬀects. On the other hand, the excess storage of lipid
occurs as a consequence of continuous oversupply of fatty
acids caused by enhanced lipolysis or adipocyte dysfunction,
together with an alteration of the fatty acid oxidation in the
mitochondria and the production of the reactive oxygen
species (ROS), a by-product of oxidative phosphorylation
[4, 5]. In particular, an altered fatty acid oxidation pathway
plays a key role in the development of hepatic steatosis
(HS) and inﬂammation on a high-fat diet [6]. The visceral
adiposity index (VAI) is a gender-speciﬁc mathematical
index based on simple anthropometric [body mass index
(BMI) and waist circumference (WC)] and metabolic [TG
and high-density lipoprotein (HDL) cholesterol] parameters
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[7]. VAI has been proposed as a surrogate marker of adipose
tissue distribution and/or dysfunction, independently corre-
lated with insulin sensitivity and cardiometabolic risk both
in the general population [8] and in patients with diﬀerent
pathologic conditions, including HS [9].
Sirtuins (Sirt), generally known as lysine deacetylases, are
a complex of proteins involved in the control of several bio-
logical processes, including lipid oxidative metabolism [10],
via the regulation of proteins’ acetylation-deacetylation path-
ways. In turn, Sirt pathways, acting as metabolic sensors in
situations of energy stress and nutrient deprivation, are
regulated by macronutrient availability [11]. Despite con-
served deacetylase domains, mitochondrial sirtuin 4 (Sirt4)
is the most eﬃcient lipoamidase among mitochondrial sir-
tuins. Sirt4 regulates the pyruvate dehydrogenase complex
via enzymatic hydrolysis of the lipoamide cofactor, thus
modulating acetyl coenzyme A production, Krebs cycle activ-
ity, and ROS generation [12]. Afterwards, it became apparent
that Sirt4 is involved in the regulation of fatty acid oxidation
in the liver [13–15]. In line with this ﬁnding, we have
reported that circulating levels of Sirt4 were reduced in obese
patients with HS, although the possible contribution of the
diet and the adipocyte dysfunction on this association was
not investigated [16].
The current study is based on the hypothesis that the
antioxidant properties of MD might be associated with the
circulating levels of Sirt4 in the obese individuals. To clarify
these associations, we investigated the possible relation-
ship between circulating levels of Sirt4 and as follows:
(i) the adherence to the MD; (ii) the single dietary com-
ponents evaluated by 7-day food records; and (iii) degree
of HS, measured by liver ultrasound and VAI, as marker
of adipocyte dysfunction.
2. Subjects and Methods
2.1. Design and Setting. This is a cross-sectional observa-
tional study carried out by the Endocrinology Unit of the
Department of Clinical Medicine and Surgery at University
Federico II in Naples (Italy). The study has been performed
in accordance with the Code of Ethics of the World Medical
Association (Declaration of Helsinki) for experiments
involving humans, and it has been approved by the Ethical
Committee of the University Federico II (n.5/14). The pur-
pose of the study was explained to both the patients and the
healthy controls, and written informed consent was obtained.
The study was conducted without any sponsorship. This
cross-sectional observational study was registered at clinical-
trials.gov (NCT02840968).
2.2. Population Study. Out of the 257 consecutive obese
subjects visiting the outpatient Obesity Unit of the Section
of Endocrinology, University of Naples Federico II, from
December 2013 to September 2015, 43 adult individuals
referred to our unit for bariatric surgery evaluation and
were enrolled in this cross-sectional observational study.
A full medical history, including drug use, was collected.
Criteria for exclusion from the study were as follows:
(a) hypocaloric diet in the last three months or speciﬁc
nutritional regimens, including vegan or vegetarian diets
(38 and two subjects, resp.); (b) the presence of liver or
renal failure, cancer, and acute or chronic inﬂammatory
diseases based on a complete medical examination and lab-
oratory investigations (seven subjects with psoriasis, three
with rheumatoid arthritis, and seven with chronic obstruc-
tive pulmonary disease); (c) occasional or current use of
drugs aﬀecting β-oxidation, including nonsteroidal anti-
inﬂammatory drugs (18 subjects), α-lipoic acid (two sub-
jects), and valproic acid (three subjects); (d) use of weight
loss medication (21 subjects) or lipid-lowering drugs (23
subjects); (e) altered thyroid hormone function tests or
thyroid hormone treatment or altered somatotropic axis
(50 subjects); (f) alcohol abuse according to the Diagnostic
and Statistical Manual of Mental Disorders- (DSM-) V diag-
nostic criteria (two subjects); and (g) vitamin/mineral or
antioxidant supplementation (32 subjects). Finally, six sub-
jects dropped out from the study since they refused to undergo
full laboratory-instrumental examinations (Figure 1).
Information on smoking habit and physical activity was
obtained by a standard questionnaire. Subjects smoking at least
one cigarette per day were considered current smokers, while
former smokers were the subjects who stopped smoking at
least one year before the interview. Remaining participants
were deﬁned as noncurrent smokers. Physical activity levels
were expressed according towhether the participant habitually
engaged at least 30min/day of aerobic exercise (YES/NO).
Physical active participants were advised to avoid the physical
activity in the 3 days before blood sampling. Participants were
classiﬁed according to their alcohol intake into two groups:
YES or NO alcohol consumption. Among alcohol consumers,
heavy alcohol consumption was deﬁned as more than two
standard drinks per day, which is equal to a daily intake
of <30g of alcohol for men and <20g of alcohol for women.
In all individuals, systolic (SBP) and diastolic (DBP)
blood pressure were measured in three times, two minutes
apart, with a random zero sphygmomanometer (Gelman
Hawksley Ltd., Sussex, UK) after the subject had been sitting
for at least 10min. The average of the second and third read-
ing was recorded.
Hypertension was deﬁned as SBP ≥ 140mmHg or
DBP ≥ 90mmHg on two diﬀerent occasions or taking antihy-
pertensive medication. Hypercholesterolemia was deﬁned as a
fasting blood total cholesterol level ≥ 190mg/dL or use of
lipid-lowering medication, hypertriglyceridaemia as fasting
blood TG levels ≥ 150mg/dL or use of lipid-lowering medica-
tion, and low HDL cholesterol was deﬁned as <40mg/dL in
men and <50mg/dL in women [17]. A history of using oral
hypoglycemic agents or a type 2 diabeteswas diagnosed accord-
ing to American Diabetes Association (ADA) criteria [18].
2.3. Anthropometric Measurements. All anthropometric
measurements were taken with subjects wearing only light
clothes and without shoes. In each subject, BMI was calcu-
lated as weight (kg)/height (m2). Height was measured to
the nearest one cm using a wall-mounted stadiometer. Body
weight was determined to the nearest 100 g using a calibrated
balance beam scale. The degree of obesity was established on
the basis of BMI cut-oﬀ points of 30.0–34.9 kg/m2 (class I
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obesity), 35.0–39.9 kg/m2 (class II obesity), and ≥40.0 kg/m2
(class III obesity) [19]. WC was measured to the closest
0.1 cm with a nonextensible tape. The measurements were
made with the subject standing upright, feet together, and
arms hanging freely at the sides, with the subjects standing
and breathing normally. WC was measured at the midpoint
between the inferior costal margin and the upper iliac crest.
According to the National Cholesterol Education Program’s
Adult Treatment Panel III (NCEP-ATP III) criteria, abdom-
inal obesity was deﬁned asWC ≥ 102 cm in men and ≥88 cm
in women [20].
2.4. Adherence to the Mediterranean Diet. The adherence to
the MD was evaluated using the previously validated 14-
item questionnaire for the assessment of PREvención con
DIeta MEDiterránea (PREDIMED) [21]. A qualiﬁed nutri-
tionist administered the questionnaire during a face-to-face
interview to all the enrolled subjects. Brieﬂy, for each item,
scores 1 and 0 were assigned; PREDIMED score was calcu-
lated as follows: 0–5, lowest adherence; score 6–9, average
adherence; and score≥ 10, highest adherence [21].
2.5. Dietary Assessment. As already reported by [22], data
were obtained during a face-to-face interview between
the patient and a qualiﬁed nutritionist. In detail, the die-
tary interview allowed to quantify foods and drinks by
using a photographic food atlas (≈1000 photographs) of
known portion sizes to ensure accurate completion of the
records [23]. Moreover, dietary data, including beverage
intakes and alcohol consumption, were collected by a 7-day
food records. The subjects returned the records to the nutri-
tionist who asked supplemental questions if necessary. Data
were stored and processed using a commercial software
(Terapia Alimentare Dietosystem® DS-Medica, http://www.
dsmedica.info). Considering quantities and qualities of
foods consumed, the software is able to calculate not only
the daily caloric intake but also the quantities of macronu-
trients (protein; total, complex, and simple carbohydrates;
total fat, SFA, monounsaturated fatty acids (MUFA),
PUFA: n-6 PUFA, n-3 PUFA, and n-6/n-3 PUFAs ratio;
cholesterol; and ﬁbers) and antioxidant nutrient intake,
such as vitamins A, C, D, and E, and iron, selenium, and
zinc. Using the same commercial software, we calculated
also the Mediterranean adequacy index (MAI), obtained
by dividing the sum of the percentages of dietary energy
from food groups typical of a healthy reference MD, by the
sum of the percentages of dietary energy of food groups that
are not characteristic of a healthy reference MD [24]:
The quality was assessed using the Index of Nutritional
Quality (INQ), which is based on the nutritional density per
1000kcal. The INQ was calculated by dividing the nutritional
intake per 1000kcal of total energy intake by the recommended
intake (RI) of protein, carbohydrate, and fat per 1000kcal. The
RI valueswere obtained from theMDrecommended, in partic-
ular, the macronutrient energy recognized as adequate in the
MD is 55–60% of carbohydrates, 10–15% of proteins, and
MAI = %en cereals + legumes + potatoes + vegetables + fruit fresh and dry + f ish + wine + virgin olive oil%enmilk + cheese + meat + eggs + animal fats andmargarines + sweet beverages + cakes/pies + cookies 1
Elegible patients:
257 adult obese individuals
Refuse to undergo full laboratory
instrumental examinations
(6 subjects)
208 patients excluded
Study population
(43 adult obese individuals) 
Hypocaloric diet in the last
three months (38 subjects)
Specic nutritional regimens
(2 subjects)
Vitamin/mineral or antioxidant
supplementation
(32 subjects) 
Alcohol abuse
(2 subjects)
Chronic inammatory
diseases (17 subjects)
Use of drugs
(67 subjects)
Endocrine dysfunctions
(50 subjects)
Figure 1: Flow chart of the study design.
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25–30% fat [25]. Each INQ value ≥ 1 0 indicates adequate
nutritional intake, while values < 1 0 indicated inadequate
nutritional status. In this study, the INQ was calculated for
protein, carbohydrate, and fat [26].
2.6. Assay Methods. Samples were collected in the morning
between 8 and 10 a.m., after an overnight fast of at least 8 h
and stored at −80°C until being processed. All biochemical
analyses including fasting plasma glucose, total cholesterol,
fasting plasma TG, alanine transaminase (ALT), aspartate
aminotransferase (AST), and γ-glutamyltransferase (γGT)
were performed with a Roche Modular Analytics System
in the Central Biochemistry Laboratory of our institution.
Low-density lipoprotein (LDL) cholesterol and HDL choles-
terol were determined by a direct method (homogeneous
enzymatic assay for the direct quantitative determination
of LDL and HDL cholesterol). Fasting insulin levels were
measured by a solid-phase chemiluminescent enzyme immu-
noassay using a commercially available kits (Immunolite
Diagnostic Products Co, Los Angeles, CA). The intra-assay
coeﬃcients of variations (CV) were <5.5%.
2.7. Metabolic Indices.Homeostasis model assessment-insulin
resistance (HoMA-IR) was calculated according to Matthews
et al. [27]: a value of HoMA− IR > 2 5 was used as cutoﬀ of
insulin resistance. VAI score has been calculated by the follow-
ing sex-speciﬁc formula, with TG levels expressed in mmol/L
and HDL levels expressed in mmol/L:
Males VAI = WC39 68 + 1 88 × BMI
× TG1 03 ×
1 31
HDL ,
Females VAI = WC36 58 + 1 89 × BMI
× TG0 81 ×
1 52
HDL
2
Age-speciﬁc VAI cut-oﬀ values were used according to
Amato et al. [8, 28]. In details, cutoﬀs in subjects aged ≤30,
31–42, 43–52, and 53–66 years were 2.52, 2.23, 1.92, 1.93,
respectively [8, 28].
2.8. Determination of Circulating Levels of Sirt4. For the
determination of circulating levels of Sirt4, venous blood sam-
ples from the antecubital vein were obtained following stan-
dard procedures. Blood was drawn into a 9mL serum tube.
Samples were centrifuged for 10min at relative centrifugal
force (RCF) of 850–1000. A part of sera was collected, ali-
quoted, and frozen at −20°C for the successive determination
of circulating levels of Sirt4. The kit for in vitro quantitative
measurement of Sirt4 in human tissue homogenates and other
biological ﬂuids, based on a sandwich enzyme immunoassay,
was provided by Uscn Life Science & Technology Com-
pany, 3603 Double Lake Dr, Missouri City, TX 77459. The
detection range was 0.156–10ng/mL, as reported elsewhere
[16]. Brieﬂy, the standard curve concentrations used for the
ELISA were 10ng/mL, 5 ng/mL, 2.5 ng/mL, 1.25 ng/mL,
0.625 ng/mL, 0.312 ng/mL, and 0.156 ng/mL. The sensitivity
of this assay was deﬁned as the lowest protein concentration
that could be diﬀerentiated from zero. It was determined by
adding two standard deviations to the mean optical density
value of twenty zero standard replicates and calculating the
corresponding concentration. The minimum detectable dose
of human Sirt4 was less than 0.051 ng/mL. No signiﬁcant
cross-reactivity or interference between human Sirt4 and
other sirtuins was observed, according to manufacturer data.
Intra-assay precision was determined as follows: three
samples with low, middle, and high level human Sirt4
were tested 20 times on one plate. The inter-assay preci-
sion was weighed testing three samples with low, middle,
and high level human Sirt4 on 3 diﬀerent plates, 8 repli-
cates in each plate. The coeﬃcient of variation, calculated
by SD/meanñ100 for the intra-assay and inter-assay was
<10% and <12%, respectively.
2.9. HS Evaluation. The presence of HS, commonly known as
“bright liver”, was assessed with a US diagnostic system
(Logiq P5, General Electric, Milan, Italy) with a 3.5MHz con-
vex probe. All the US determinations were made by the same
trained operator. The intraoperator variability, as evaluated
in 20 subjects within 1 week from the ﬁrst ultrasonographic
examination, showed an overall r value of 0.92 (p < 0 001).
The classiﬁcation of “bright liver” or HS was based on the
following scale of hyperechogenicity: grade 0=absent, grade
1= light, grade 2=moderate, and grade 3=severe, pointing out
the diﬀerence between the densities of the liver and the right kid-
ney [29]. Technically, echo intensity can be inﬂuenced by many
factors, particularly by gain intensity. To avoid confounding
factors that could modify echo intensity and thus bias compari-
sons, mean brightness levels of both liver and right kidney cor-
tex were obtained on the same longitudinal sonographic plane.
2.10. StatisticalMethods.Theminimum required total sample
was calculated using the pooled standard deviation with the
level test 0.05 and power 90% of means the circulating levels
of Sirt4 in obese patients.With a type I error of 0.10 and a type
of II (β) error of 0.05, the resulting size was 13 subjects.
Results are expressed as mean± SD or as median plus
range according to the variable’s distributions evaluated by
Kolmogorov-Smirnov test. To correct for skewed distribu-
tions, circulating levels of Sirt4 were logarithmically trans-
formed and back-transformed for presentation in tables
and ﬁgures.
Diﬀerences between two groups were analyzed byMann–
Whitney U test or Student’s unpaired t-test, when appro-
priate. Diﬀerences among three groups were analyzed by
the Kruskal-Wallis rank test or ANOVA test, with the
Bonferroni test as post hoc test, according to the variable’s
distribution. The chi2 (χ2) test was used to test the signiﬁcance
of diﬀerences in frequency distributions. The correlations
between variables were performed using Spearman’s rho
correlation coeﬃcients. Multinomial logistic regression was
performed to model the relationship between the circulating
levels of Sirt4 and the three groups of HS classiﬁcation
(grade 1, grade 2, and grade 3).
Bivariate proportional odds ratio (OR) models and 95%
interval conﬁdence (IC) were performed to assess the
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association among quantitative variables (all food items of the
PREDIMED questionnaire and PREDIMED score). A multiple
linear regression model with ordinal predictors was designed to
identify critical threshold values (m), expressed as R2, beta (β),
and t, of the PREDIMED score at which signiﬁcant changes
occur in the response circulating levels of Sirt4, as follows:
For the calculation of ODDS, circulating levels of Sirt4 were
dichotomized in two categories, below and above the median
(medianof circulating levels of Sirt4was 0.42ng/mL). The calcu-
lation ofORwas obtained of bivariate regression analysismodel.
Circulating levels of Sirt4i = β0 + β1PREDIMED scorei1 +⋯ + βm−1PREDIMED scorei,m−1 + εi 3
Table 1: Circulating levels of Sirt4 in the study population according to gender, obesity-related morbidities, cardiometabolic indices, HS, and
major lifestyle factors.
Parameters
Circulating levels of Sirt4 (ng/mL)
n = 43
Median (min–max) p value
Gender
Males 0.37 (0.10–2.75)
0.406
Females 0.68 (0.11–5.56)
Hypertension
Yes 0.15 (0.10–0.42) <0.001
No 1.22 (0.11–5.56)
Hypercholesterolaemia
Yes 0.28 (0.11–2.51)
0.015
No 0.24 (0.10–5.56)
Hypertriglyceridaemia
Yes 0.28 (0.11–2.39)
0.018
No 1.30 (0.10–5.56)
HDL cholesterol
<cutoﬀ 0.18 (0.10–1.26) <0.001>cutoﬀ 1.88 (0.16–5.56)
Type 2 diabetes
Yes 0.15 (0.10–1.11)
0.001
No 0.97 (0.11–5.56)
VAI
>cutoﬀ 0.29 (0.10–2.66) <0.001<cutoﬀ 3.23 (1.22–5.56)
HS
Grade 1 (mild) 3.79 (1.33–5.56)
Grade 2 (moderate) 2.80 (1.66–3.42) 0.007
Grade 3 (severe) 0.24 (0.18–0.37)
Current smokers
Yes 0.16 (0.10–1.22)
0.001
No 1.26 (0.11–5.56)
Physical activity
No 0.29 (0.10–2.51)
0.001
Yes 2.75 (0.11–5.56)
Alcohol consumption
Yes 1.94 (0.10–3.42)
0.190
No 0.38 (0.11–5.56)
Circulating levels of Sirt4 were lower in individuals with obesity-related comorbidities, adiposity dysfunction, HS, current smokers, and physically inactive
individuals. As HoMA-IR and FLI were increased in all the study population, these variables were not included in this analysis. Circulating levels of Sirt4
were signiﬁcantly diﬀerent in the presence of obesity-related comorbidities, adiposity dysfunction, HS, and among current smokers or physically inactive
individuals, while there were no signiﬁcant diﬀerences according to gender and alcohol consumption. Results are expressed as median plus range according
to variable distributions evaluated by Kolmogorov-Smirnov test. Diﬀerences between two groups were analyzed by Mann–Whitney U test. Diﬀerences
among HS grades were analyzed by the Kruskal-Wallis rank test followed by Bonferroni post hoc test. A p value in bold type denotes a signiﬁcant diﬀerence
(p < 0 05). Hypertension was deﬁned as SBP ≥ 140mmHg or DBP ≥ 90mmHg on two diﬀerent occasions or taking antihypertensive medication.
Hypercholesterolemia was deﬁned as a fasting blood total cholesterol level ≥ 190mg/dL or use of lipid-lowering medication, hypertriglyceridaemia was
deﬁned as fasting blood triglyceride levels ≥ 150mg/dL or use of lipid-lowering medication, and low HDL cholesterol was deﬁned as <40mg/dL in men and
<50mg/dL in women [17]. A history of using oral hypoglycemic agents or a type 2 diabetes was diagnosed according to American Diabetes Association
(ADA) criteria [18]. Age-speciﬁc VAI cut-oﬀ values were used according to Amato et al. [8, 25]. In detail, cutoﬀs in subjects aged ≤30, 31–42, 43–52, and
53–66 years were 2.52, 2.23, 1.92, and 1.93, respectively [8, 25]. The classiﬁcation of “bright liver” or HS was based on the following scale of
hyperechogenicity: grade 0 = absent, grade 1 = light, grade 2 =moderate, and grade 3 = severe, pointing out the diﬀerence between the densities of the liver
and the right kidney [26]. Subjects smoking at least one cigarette per day were considered current smokers. Physical activity levels were expressed according
to whether the participant habitually engaged at least 30 min/day of aerobic exercise. Among alcohol consumers, heavy alcohol consumption was deﬁned as
more than two standard drinks per day, which is equal to a daily intake of <30 g of alcohol for men and <20 g of alcohol for women. Sirt4: sirtuin 4; HDL:
high-density lipoprotein; VAI: visceral adiposity index; HS: hepatic steatosis.
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In addition, twomultiple linear regression analysismodels
(stepwise method), expressed as R2, beta (β), and t, with cir-
culating levels of Sirt4 as dependent variables were used to
estimate the predictive value of the following: (a) all food
items of PREDIMED questionnaire and PREDIMED score
and (b) total energy, SFA, n-3 PUFA, vitamin C, and vitamin
E. In these analyses, we entered only those variables that had
a p value < 0.05 in the univariate analysis (partial correlation).
To avoid multicollinearity, variables with a variance inﬂation
factor (VIP) >10 were excluded.Values ≤ 5%were considered
statistically signiﬁcant. Data were stored and analyzed using
the MedCalc® package (Version 12.3.0 1993–2012 MedCalc
Software bvba-MedCalc Software, Mariakerke, Belgium).
Multinomial logistic regression, bivariate proportional OR
model, and multiple linear regression model were carried
out using the R Project for Statistical Computing 2014
(http://www.R-project.org).
3. Results
All participants to the study completed the PREDIMED
questionnaires and the 7-day food records. Study population
consisted of 43 obese patients, aged 25–53 years (44%,
19 males). BMIs ranged from 36.7 to 58.8 kg/m2 (88.4%,
38 subjects were class III–obesity), 27.9% (12 subjects) were
hypertensive, and 20.9% (9 subjects) had diagnosis of type 2
diabetes. Median values of HoMA-IR range from 2.5 to
15.7. Median of VAI was 5.3 (1.6–17.3). In particular,
VAI was higher than sex and age-speciﬁc cutoﬀs in 79.1%
(34 subjects). Moderate/severe HS was diagnosed in 90.7%
(39 subjects). Current smokers were 32.6% (14 subjects)
and alcohol consumption was reported in 30.2% (13 sub-
jects). A moderate-intensity aerobic activity at least 5 days
per week was reported in 25.6% (11 subjects). Among phys-
ical active participants, no subject engaged more than
30min/day/week.
Circulating levels of Sirt4 according to gender, obesity-
related comorbidities, metabolic indices, HS, and major life-
style factors are reported in Table 1. As shown in the table,
circulating levels of Sirt4 were signiﬁcantly diﬀerent in the
presence of obesity-related comorbidities, adiposity dysfunc-
tion, HS, and among current smokers or physically inactive
individuals, while there were no signiﬁcant diﬀerences
according to gender and alcohol consumption.
Response frequency of dietary components included in
the PREDIMED questionnaire of the patients is reported in
Table 2. Extra virgin olive oil was the most consumed food
item, followed by ﬁsh with the wine intake in third position.
According to the PREDIMED score, all obese participants
had a low (PREDIMED score≤ 5) or average adherence
(PREDIMED score 6–9) to theMD, with no subjects reaching
a score indicating a high adherence to the MD.
In particular, on the basis of the PREDIMED score,
obese participants were divided into low (37.2%) and aver-
age adherence (62.8%). Study participants’ characteristics
grouped according to the PREDIMED score are summarized
in Table 3. As shown in table, obese subjects with low
adherence to the MD presented with much lower circulating
levels of Sirt4, higher BMI, and more altered metabolic
indices than average adherers. No diﬀerences were observed
in age and male-to-female ratio.
In Table 4, we reported the total energy and the daily
macronutrients/micronutrients intake obtained from the
7-day food records. As shown in the table, obese individuals
with low MD adherence had signiﬁcantly higher energy
intake and percentage of energy from lipids, mainly SFA
and PUFA, and a signiﬁcantly lower ﬁber intake than average
adherers. In addition, low adherers consumed signiﬁcantly
lower complex carbohydrates and antioxidant nutrient
intake than average adherers, including n-3 PUFA, A, C,
and E vitamins, and micronutrients. In addition, as expected,
obese individuals with lowMD adherence presented INQ < 1
for protein, carbohydrate, and fat and lower MAI compared
with average adherers.
3.1. Correlation Studies. The correlations among circulating
levels of Sirt4, anthropometric measurements, and metabolic
parameters are summarized in Table 5. In Table 6, the multi-
nomial logistic regression of circulating levels of Sirt4 with
HS grade are reported. The highest circulating levels of Sirt4
were associated with the lowest odds of HS (grade 1),
p = 0 002, R2 = 0 861, and AIC=56.623.
The results of bivariate proportional odds ratio model
performed to assess the association of circulating levels of
Sirt4 with food items of PREDIMED questionnaire, and
PREDIMED score are reported in Table 7. In obese
patients, the lowest decrease in circulating levels of Sirt4
was signiﬁcantly associated with the highest odds of con-
sumption of the Mediterranean food items, in particular
fruits (p = 0 002), extra virgin olive oil (p = 0 004), vegetables
(p = 0 008), ﬁsh (p = 0 011), and wine (p = 0 018), and with
highest score of adherence of MD (p = 0 004). On the con-
trary, the highest decrease in circulating levels of Sirt4 was
signiﬁcantly associated with the highest odds of consumption
Table 2: Response frequency of dietary components included in the
PREDIMED questionnaire of the patients.
Questions in PREDIMED questionnaire n %
(1) Use of extra virgin olive oil as main culinary lipid 33 76.7
(2) Extra virgin olive oil> 4 tablespoons 22 51.2
(3) Vegetables≥ 2 servings/day 21 48.8
(4) Fruits≥ 3 servings/day 18 41.9
(5) Red/processed meats< 1/day 21 48.8
(6) Butter, cream, margarine< 1/day 19 44.2
(7) Soda drinks< 1/day 10 23.3
(8) Wine glasses≥ 7/week 24 55.8
(9) Legumes≥ 3/week 21 48.8
(10) Fish/seafood≥ 3/week 25 58.1
(11) Commercial sweets and confectionery≤ 2/week 12 27.9
(12) Tree nuts≥ 3/week 13 30.2
(13) Poultry more than red meats 21 48.8
(14) Use of sofrito sauce≥ 2/week 23 53.5
Extra virgin olive oil was the most consumed food item, followed by
ﬁsh and wine intake. Results are expressed as percentage of response
obtained with PREDIMED questionnaire. PREDIMED: PREvención con
DIetaMEDiterránea ([20] in the text).
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of butter (p = 0 015). In Table 8, the correlations among cir-
culating levels of Sirt4, PREDIMED score, total energy and
daily macronutrients/micronutrients intake, INQ, and MAI
evaluated by using the 7-day food records are reported.
As expected, INQ and MAI showed a highly positive correla-
tion with PREDIMED score (INQ protein, r = 0 793; INQ
carbohydrates, r = 0 824; INQ fat, r = 0 846; MAI, r = 0 974;
p < 0 001, respectively). Circulating levels of Sirt4 correlated
with PREDIMED score and MAI (p < 0 001), with all the
dietary macronutrients and micronutrients, except for total
carbohydrates and PUFA (p = 0 430) and INQ for each mac-
ronutrient (p < 0 001). After adjusting for total energy intake,
all the associations were lost, except for PREDIMED score
(p = 0 021), INQ protein (p = 0 003), the consumption of
fat SFA (p = 0 016) and n-3 PUFA (p < 0 001), and the
intake of vitamins C and E (p < 0 001 and p = 0 034,
respectively); as shown in Table 8. To compare the relative
predictive power of the food items included in the PRE-
DIMED and the score of adherence to the MD associated
with the circulating levels of Sirt4, we performed a multiple
linear regression analysis using models that included as mea-
sures of the consumption frequency of each food items of
PREDIMED questionnaire along with the PREDIMED score.
Using these models, PREDIMED score entered at the ﬁrst
step (p < 0 001) and followed by the fruit consumption ≥ 3
serving/day (p = 0 009). To compare the relative predictive
power of the intake of food and beverage associated with
the circulating levels of Sirt4, we performed a multiple linear
regression analysis using models that included as measures of
the intake of the single micro and macronutrients obtained
by the 7-day food records. Using these models, n-3 PUFA
entered at the ﬁrst step (p < 0 001), followed by vitamin E
Table 3: Sociodemographic and anthropometric characteristics, metabolic proﬁle, and circulating levels of Sirt4 in obese individuals grouped
on the basis of the adherence to the Mediterranean diet.
Parameters
Obese
Low adherence MD
n = 16
Obese
Average adherence MD
n = 27
p value
Age (years) 38.1± 3.4 35.9± 7.7 0.356
Gender M/F 8/8 11/16 0.784
Anthropometric measurement
BMI (kg/m2) 52.0± 3.4 42.4± 2.9 <0.001
WC males (cm) 151.1± 9.8 136.8± 11.6 0.012
WC females (cm) 144.4± 17.1 125.4± 15.4 0.012
Metabolic proﬁle
Circulating levels of Sirt4 (ng/mL) 0.16 (0.10–0.29) 1.33 (0.11–5.56) <0.001
SBP (mmHg) 136.0± 12.4 127.4± 10.7 0.022
DBP (mmHg) 85.0 (70.0–100.0) 80.0 (60.0–95.0) 0.090
Fasting glucose (mg/dL) 109.0 (73.0–143.0) 94.0 (68.0–193.0) 0.004
Insulin (μU/mL) 36.1± 7.9 26.7± 8.5 0.001
Total cholesterol (mg/dL) 211.1± 31.9 179.4± 27.4 0.003
HDL cholesterol (mg/dL) 36.8± 6.1 51.3± 11.1 <0.001
LDL cholesterol (mg/dL) 134.9± 23.0 102.8± 26.5 <0.001
Triglycerides (mg/dL) 171.5 (89.0–380.0) 101.0 (49.0–283.0) 0.015
ALT (U/L) 38.0 (12.0–91.0) 32.0 (13.0–99.0) 0.439
AST (U/L) 25.0 (12.0–52.0) 23.0 (10.0–91.0) 0.793
γGT (U/L) 30.0 (12.0–61.0) 30.5 (14.0–101.0) 0.776
Metabolic indices
HoMA-IR 10.0± 3.0 6.4± 2.4 <0.001
VAI 8.5 (3.3–17.3) 4.7 (1.6–15.8) 0.003
HS evaluation
HS (grade 1/2/3) 0/1/15 4/9/14 <0.001
FLI 99.9 (98.8–100.0) 98.7 (80.3–99.9) <0.001
Obese individuals with low adherence to the MD exhibited statistically signiﬁcant diﬀerences in anthropometric measurements, metabolic proﬁle, metabolic
indices, and HS evaluation compared with average adherer counterpart. No diﬀerences were observed in age and male-to-female ratio. Results are expressed
as mean ± standard deviation or as median plus range according to variable distributions evaluated by Kolmogorov–Smirnov test. Diﬀerences between
groups were analyzed by unpaired Student’s t-test or Wilcoxon signed-rank test, when appropriate. The chi2 (χ2) test was used to test the signiﬁcance of
diﬀerences between the two groups. p value indicates comparison between those with low adherence versus those with average adherence to the MD.
A p value in bold type denotes a signiﬁcant diﬀerence (p < 0 05). MD: Mediterranean diet; BMI: body mass index; WC: waist circumference; Sirt4:
sirtuin 4; SBP: systolic blood pressure; DBP: diastolic blood pressure; HDL: high-density lipoprotein; LDL: low-density lipoprotein; ALT: alanine
aminotransferase; AST: aspartate aminotransferase; γGT: gamma glutamyl transferase: HoMA-IR: homeostatic model assessment-insulin resistance;
VAI: visceral adiposity index; HS: hepatic steatosis; FLI: fatty liver index.
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(p < 0 001) and vitamin C (p = 0 048); results are reported in
Table 9.
Based on the multiple linear regression analysis with
ordinal predictors, the most signiﬁcant (α = 0 05) thresh-
old value of the PREDIMED score predicting the lowest
decrease in circulating levels of Sirt4 was found at a score
of 6 (p < 0 001) (Figure 2).
4. Discussion
The present study evidenced a positive association between
adherence to the MD and circulating levels of Sirt4 in obese
individuals. In addition, a careful investigation of the dietary
pattern using the 7-day food records demonstrated that the
circulating levels of Sirt4 are negatively correlated with
energy intake, and positively with the intake of antioxidant
vitamins and minerals considered in this study. Finally,
we found that circulating levels of Sirt4 were negatively
correlated with surrogate markers of ectopic fat storage
and visceral fat dysfunction, independently of the severity
of the obesity. Of interest, although experimental studies evi-
denced that physical activity might aﬀect the Sirt4 expression
[30], we found that the associations between Sirt4 and vari-
ables included in this study remained signiﬁcant also after
adjusting for physical activity.
We previously reported that in obese individuals with
higher degree of HS, there were lower circulating levels of
Sirt4 [16]. Although in our preliminary study, we hypothe-
sized the involvement of a high calorie intake in reducing cir-
culating levels of Sirt4; the possible inﬂuence of the dietary
pattern on the circulating levels of Sirt4 was not investigated.
The present study further extends our previous observa-
tions as it demonstrates that lower circulating levels of Sirt4
were actually associated with a speciﬁc dietary pattern in
Table 4: Total energy and daily macronutrient/micronutrient intake of obese individuals grouped on the basis of the adherence to the
Mediterranean diet.
Parameters
Obese
Low adherence MD
n = 16
Obese
Average adherence MD
n = 27
p value
Total energy (kcal) 3473.1± 271.9 2822.3± 287.7 <0.001
Protein (% of total kcal) 14.0 (11.0–18.0) 16.0 (12.0–20.0) 0.045
INQ protein 0.98± 0.03 1.08± 0.07 <0.001
Carbohydrate (% of total kcal) 56.0 (53.0–61.0) 57.0 (54.0–60.0) 0.469
INQ carbohydrate 0.97± 0.03 1.03± 0.03 <0.001
Complex (% of total kcal) 28.8± 5.5 31.8± 4.0 0.049
Simple (% of total kcal) 27.8± 4.5 25.2± 4.0 0.055
Fat (% of total kcal) 29.0 (28.0–30.0) 27.0 (25.0–30.0) <0.001
INQ Fat 0.96± 0.03 1.06± 0.05 <0.001
SFA (% of total kcal) 11.5 (8.3–15.7) 9.0 (1.7–10.3) <0.001
MUFA (% of total kcal) 12.8 (11.2–14.3) 15.7 (14.5–17.7) <0.001
PUFA (% of total kcal) 3.3 (1.8-9.3) 2.9 (1.8–5.9) 0.191
n-6 PUFA (g/day) 10.9 (4.8–34.7) 5.7 (0.4–15.4) 0.001
n-3 PUFA (g/day) 2.2 (0.6–2.8) 3.4 (1.3–12.4) <0.001
n-6/n-3 PUFAs ratio 5.9 (2.1–20.8) 1.6 (0.1–11.8) <0.001
Cholesterol (mg/day) 335.9± 42.2 323.0± 32.2 0.262
Fiber (g/day) 20.4 (8.2–25.0) 24.0 (10.1–28.1) 0.021
Retinol Eq (μg/day) 756.5 (451.0–1990.0) 1249.0 (527.0–2012.0) 0.001
Vitamin C (mg/day) 71.0± 26.3 159.0± 44.7 <0.001
Vitamin D (μg/day) 1.6± 0.6 2.1± 0.7 0.014
Vitamin E (mg/day) 10.5± 1.6 16.4± 2.3 <0.001
Iron (mg/day) 8.2± 1.9 10.6± 2.9 0.005
Selenium (μg/day) 15.2 (9.0–33.9) 22.1 (8.7–42.5) 0.003
Zinc (mg/day) 8.8± 1.5 10.4± 1.3 <0.001
MAI 1.09± 0.34 3.18± 0.81 <0.001
Obese individuals with lowMD adherence had a higher energy intake, a higher percentage of energy from lipids, mainly SFA and PUFA, and a lower ﬁber intake
than average adherers. Low adherers consumed lower complex carbohydrates and lower antioxidant intake than average adherers, including n-3 PUFA, A, C,
and E vitamins, andmicronutrients. Results are expressed as mean ± standard deviation or as median plus range according to variable distributions evaluated by
Kolmogorov-Smirnov test. Diﬀerences between groups were analyzed by unpaired Student’s t-test or Wilcoxon signed-rank test, when appropriate. p value
indicates comparison between those with low adherence versus those with average adherence to the MD. A p value in bold type denotes a signiﬁcant
diﬀerence (p < 0 05). MD: Mediterranean diet; INQ: index of nutritional quality; SFA: saturated fatty acids; MUFA: monounsaturated fatty acids; PUFA:
polyunsaturated fatty acids; MAI: Mediterranean adequacy index.
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obese individuals. In particular, the classiﬁcation of patients
according to the degree of adherence to theMDdemonstrated
that subjects with an average adherence presented a lower
reduction in circulating levels of Sirt4 when compared to sub-
jects with a low adherence, independently of age and gender,
with a PREDIMED score ≥ 6 predicting the lowest decrease
in circulating levels of Sirt4. Next, the study demonstrated that
the highest consumption of food items characteristic of the
MD, such as fruits, extra virgin olive oil, vegetables, and ﬁsh,
was associated with a lowest decrease in circulating levels of
Sirt4. The positive association between adherence to the MD
and circulating levels of Sirt4 is consistent with the diet-
induced modiﬁcations in Sirt1 [31] in the larger context of
the diet-induced, epigenetic mechanisms [32]. This observa-
tion could be of potential interest considering the emerging
role of Sirt4 as tumour suppressor recently reported in
diﬀerent human tumour cell lines [33] and the well-known
antitumour properties of the MD [34, 35].
The 7-day reports allowed us to obtain detailed informa-
tion on the diet composition in subjects with low and average
adherence to the MD. As expected, we found a highly signif-
icant correlation between PREDIMED score and MAI, an
index developed to assess how close a diet is to the Healthy
Reference National Mediterranean Diet [36]. When com-
pared with average adherers, low adherers had a higher
total energy intake, higher consumption of fat, mainly SFA
and n-6 PUFA, and lower consumption of complex carbo-
hydrate, protein, MUFA, n-3 PUFA, and ﬁber, and lower
INQ for macronutrients. Consequently, low adherers had a
low intake of all antioxidants considered in this study. Of
Table 5: Correlations among circulating levels of Sirt4 with demographics, anthropometric measurements, metabolic proﬁle, metabolic
indices, and HS evaluation.
Parameters
Circulating levels of Sirt4 (ng/mL)
n = 43
Simple correlation Adjusted for BMI
r p value r p value
Age (years) −0.363 0.017 −0.249 0.122
Anthropometric measurement
BMI (kg/m2) −0.804 <0.001 — —
WC (cm) −0.707 <0.001 −0.339 0.033
Metabolic proﬁle
SBP (mmHg) −0.512 <0.001 0.038 0.817
DBP (mmHg) −0.318 0.038 0.075 0.645
Fasting glucose (mg/dL) −0.369 0.015 −0.067 0.679
Insulin (μU/mL) −0.543 <0.001 −0.147 0.366
Total cholesterol (mg/dL) −0.522 <0.001 −0.257 0.109
HDL cholesterol (mg/dL) 0.814 <0.001 0.434 0.005
LDL cholesterol (mg/dL) −0.642 <0.001 −0.276 0.085
Triglycerides (mg/dL) −0.454 0.002 −0.246 0.126
ALT (U/L) 0.081 0.611 0.130 0.424
AST (U/L) -0.015 0.926 0.041 0.801
γGT (U/L) 0.117 0.468 −0.006 0.971
Metabolic indices
HoMA-IR −0.627 <0.001 −0.111 0.497
VAI -0.559 <0.001 −0.329 0.038
HS evaluation
FLI −0.762 <0.001 −0.633 <0.001
Correlations among variables were performed using Spearman’s rho correlation coeﬃcients. Circulating levels of Sirt4 were signiﬁcantly associated with BMI,
WC, metabolic proﬁle, and the metabolic indices. After adjusting for BMI, the associations between circulating levels of Sirt4 and the study variables were not
signiﬁcant, except for WC, HDL cholesterol, VAI, and FLI. A p value in bold type denotes a signiﬁcant diﬀerence (p < 0 05). Sirt4: sirtuin 4; BMI: body mass
index;WC: waist circumference; SBP: systolic blood pressure; DBP: diastolic blood pressure; HDL: high-density lipoprotein; LDL: low-density lipoprotein; ALT:
alanine aminotransferase; AST: aspartate aminotransferase; γGT: gamma glutamyl transferase; HoMA-IR: homeostatic model assessment-insulin resistance;
VAI: visceral adiposity index; HS: hepatic steatosis; FLI: fatty liver index.
Table 6: Multinomial logistic regression of circulating levels of Sirt4
with HS grade.
HS OR p value 95% IC
Grade 1 = light 9.47 0.002 7.02–12.77
Grade 2 =moderate 3.22 0.005 2.39–4.35
Grade 3 = severe 1.00 0.003 0.74–1.34
Multinomial logistic regression of circulating levels of Sirt4 with HS
grade. The highest levels of Sirt4 were associated with the lowest odds
of HS (grade 1). A p value in bold type denotes a signiﬁcant diﬀerence
(p < 0 05). Sirt4: sirtuin 4; HS: hepatic steatosis; OR: odds ratio; IC:
interval conﬁdence.
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Table 7: Bivariate proportional odds ratio model to assess the association between circulating levels of Sirt4 and food items included in the
PREDIMED questionnaire.
Questions OR p value 95% IC AIC R2adj
(1) Use of extra virgin olive oil as main culinary lipid
0.004 39.484 0.239Yes 2.60 1.93–3.51
No 1.04 0.77–1.40
(2) Extra virgin olive oil> 4 tablespoons
0.234 62.069 0.254Yes 0.74 0.55–1.00
No 3.65 2.70–4.92
(3) Vegetables≥ 2 servings/day
0.008 53.157 0.175Yes 2.61 1.93–3.52
No 1.03 0.77–1.44
(4) Fruits≥ 3 servings/day
0.002 46.918 0.265Yes 3.44 2.55–4.63
No 0.78 0.58–1.06
(5) Red/processed meats< 1/day
0.246 62.15 0.024Yes 1.33 0.98–1.79
No 2.04 1.51–2.75
(6) Butter, cream, margarine< 1/day
0.015 52.652 0.175Yes 0.35 0.26–0.43
No 7.74 5.74–10.44
(7) Soda drinks< 1/day
0.593 50.37 0.058Yes 1.14 0.85–1.54
No 2.36 1.75–3.19
(8) Wine glasses≥ 7/week
0.018 54.708 0.140Yes 2.41 1.78–3.25
No 1.12 0.83–1.52
(9) Legumes≥ 3/week
0.067 59.615 0.066Yes 1.65 1.23–2.23
No 1.63 1.21–2.20
(10) Fish/seafood≥ 3/week
0.011 50.762 0.200Yes 3.36 2.49–4.53
No 0.80 0.59–1.08
(11) Commercial sweets and confectionery≤ 2/week
0.095 52.011 0.057Yes 1.53 1.13–2.06
No 1.77 1.31–2.39
(12) Tree nuts≥ 3/week
0.220 55.183 0.028Yes 1.35 1.00–1.82
No 2.01 1.49–2.71
(13) Poultry more than red meats
0.146 61.239 0.039Yes 1.45 1.07–1.96
No 1.86 1.38–2.52
(14) Use of sofrito sauce≥ 2/week
0.107 60.355 0.051Yes 1.56 1.15–2.10
No 1.74 1.29–2.34
PREDIMED score
0.010 20.409 0.710Low adherence MD (score≤ 5) 3.02 2.24–4.08
Average adherence MD (6≤ score≤ 9) 8.97 1.21–6.65
Circulating levels of Sirt4 were associated with the highest odds of consumption fruits, extra virgin olive oil, vegetables, ﬁsh, and wine and with highest score of
adherence of MD. On the contrary, the highest levels of Sirt4 were signiﬁcantly associated with the lowest odds of consumption of butter. A p value in bold type
denotes a signiﬁcant diﬀerence (p < 0 05). PREDIMED: PREvención con DIeta MEDiterránea; OR: odds ratio; IC: interval conﬁdence; AIC: Akaike information
criterion.
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interest, after adjusting these results for total energy intake,
circulating levels of Sirt4 remained signiﬁcantly and posi-
tively associated only with the consumption of nutrients with
the highest antioxidant properties, such as n-3 PUFA and
vitamins C and E, and negatively correlated with the con-
sumption of SFA. The positive association of Sirt4 levels with
dietary antioxidant intake and the negative association with
VAI might be of particular interest considering the involve-
ment of visceral adiposity in low-grade inﬂammation [7, 8]
and the well-described eﬀects of MD in inﬂammatory gene
expression [37]. Using the multivariate analysis model, circu-
lating levels of Sirt4 were well predicted by the PREDIMED
score and the consumption n-3 PUFA.
As expected, obese subjects with a low adherence to MD
presented worse anthropometric measurements and meta-
bolic proﬁle. In addition, as expected, low adherence to MD
was associated to a higher HS grade when compared with
subjects with an average adherence, independently of age
and gender. Besides HS, this study reported a novel associa-
tion between adherence to the MD and circulating levels of
Sirt4 with VAI, a well validated, reliable, and widely used
marker of ectopic visceral distribution and function [28]. In
particular, VAI was higher in low adherers compared with
average adherers and showed a negative correlation with
circulating levels of Sirt4.
Taking together the results of this study: (i) lend support
to the hypothesis that the increase in energy intake in obese
individuals was associated with blunted circulating levels of
Sirt4 as an adaptive mechanism to decrease fat oxidative
capacity, but promoting lipid storage in ectopic tissues; (ii)
suggest that the healthy combination of antioxidant vitamins
and minerals characteristic of the MD could contribute to
dampen this mechanism, probably reducing the oxidative
damage and the ectopic fat storage. In line with this
Table 8: Correlations of circulating levels of Sirt4 with PREDIMED score, total energy, and daily macronutrient/micronutrient intake.
Parameters
Circulating levels of Sirt4 (ng/mL)
n = 43
Simple correlation Adjusted for total energy (kcal)
r p value r p value
PREDIMED score 0.820 <0.001 0.356 0.021
Total energy (kcal) −0.818 <0.001 — —
Protein (% of total kcal) 0.511 <0.001 0.100 0.529
INQ protein 0.742 <0.001 0.453 0.003
Carbohydrate (% of total kcal) −0.070 0.656 −0.033 0.838
INQ carbohydrate 0.661 <0.001 0.184 0.242
Complex (% of total kcal) 0.395 0.009 0.082 0.606
Simple (% of total kcal) −0.472 0.001 −0.133 0.477
Fat (% of total kcal) −0.822 <0.001 −0.280 0.073
INQ Fat 0.578 <0.001 0.060 0.704
SFA (% of total kcal) −0.730 <0.001 −0.370 0.016
MUFA (% of total kcal) 0.739 <0.001 0.138 0.384
PUFA (% of total kcal) −0.124 0.430 0.050 0.754
n-6 PUFA (g/day) −0.546 <0.001 −0.107 0.502
n-3 PUFA (g/day) 0.854 <0.001 0.646 <0.001
n-6/n-3 PUFAs ratio −0.541 <0.001 0.123 0.438
Cholesterol (mg/day) −0.336 0.028 −0.007 0.964
Fiber (g/day) 0.305 0.047 −0.026 0.872
Retinol Eq (μg/day) 0.337 0.027 −0.029 0.854
Vitamin C (mg/day) 0.825 <0.001 0.476 0.001
Vitamin D (μg/day) 0.407 0.007 0.083 0.601
Vitamin E (mg/day) 0.834 <0.001 0.329 0.034
Iron (mg/day) 0.335 0.028 0.067 0.673
Selenium (μg/day) 0.421 0.005 0.205 0.192
Zinc (mg/day) 0.505 0.001 0.020 0.900
MAI 0.833 <0.001 0.435 0.004
Correlations among variables were performed Spearman’s rho correlation coeﬃcients. Circulating levels of Sirt4 were signiﬁcantly associated with all the
macronutrients/micronutrients evaluated in this study, except with carbohydrate and n-6 PUFA. After adjusting for total energy intake, the associations
between circulating levels of Sirt4 and the study variables were lost, except for PREDIMED score, the consumption of fat, SFA and n-3 PUFA, and the
intake of vitamins C and E. Sirt4: sirtuin 4; PREDIMED: PREvención con DIeta MEDiterránea; INQ: index of nutritional quality; SFA: saturated fatty acids;
MUFA: monounsaturated fatty acids; PUFA: polyunsaturated fatty acids; MAI: Mediterranean adequacy index.
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hypothesis, circulating levels of Sirt4 were well predicted by
either the adherence to the MD and the intake of speciﬁc
nutrients with antioxidant properties, independently of
the energy intake; (iii) let us hypothesize that circulating
levels of Sirt4, similarly to Sirt1, might undergo diet-
induced epigenetic modiﬁcations, thus contributing to the
antitumour properties of healthy diets, such as MD; and
(iv) evidence that the lowest circulating levels of Sirt4 were
associated not only to the highest grade of HS but also to
the highest visceral fat dysfunction, independently of the
severity of the obesity and physical activity.
Despite these very interesting results, the main limitation
of this study is that the cross-sectional design does not allow
to identify any causal association between the variables
included. Second, we are aware that the sample size is small
and the BMI range is wide and is not a measurement of body
composition [38]. Nevertheless, we found that circulating
levels of Sirt4 were negatively correlated to VAI, an index
that incorporates also waist circumference, a far more accu-
rate benchmark for visceral adiposity, also independently of
BMI. Third, we do not provide experimental data on muscle
biopsy sample between tissue expression and circulating
levels of Sirt4; thus, our hypothesis of a compensative regula-
tion of Sirt4 by diet remains speculative. Furthermore, the
suggested value of the PREDIMED score for the recognition
of the lowest decrease in circulating levels of Sirt4 should
be viewed with caution until results will be extended to
larger patient populations in order to perform an appro-
priate cross-validation. However, this study has adequate
statistical power, the observed diﬀerences between low
and average adherers were statistically signiﬁcant, and
correlations have been adjusted for BMI. In addition, in
order to improve the power of the study, very stringent
inclusion criteria have been applied, such as normal thy-
roid function or, according to our recent observations
[39], normal somatotropic axis. Finally, the strength of
this study is the usage of the 7-day food records. Although
one week may not be representative of their usual dietary
habits, this method of dietary assessment is considered as
the “gold standard” in validation studies of diﬀerent types
of self-administered food frequency questionnaires, allow-
ing a more accurate measurement of the real dietary and
macronutrient intakes compared to those obtained by ret-
rospective food frequency questionnaires [40, 41]. In addi-
tion, to reduce the eﬀect of over- or under-reporting of
individual foods, nutrient intake was adjusted for total
energy intake.
Thus, although the results were partially limited due
to the lack of speciﬁc markers of oxidative stress, the
detailed information on the diet composition obtained by
the 7-day food records was consistent with a more reduced
intake of antioxidant nutrients in low adherers compared
with average adherers.
4.1. Conclusions. A lower reduction in circulating levels of
Sirt4 was found in obese individuals with average adherence
to the MD compared with low adherers, in association
with lower ectopic fat storage and adipocyte dysfunction,
independently of BMI. Circulating levels of Sirt4 varied
in association not only with energy intake but also with
antioxidant nutrient intake. The positive association
between the adherence to the MD and circulating levels
of Sirt4 suggests that the Sirt4 increase might represent
further aspects of the antioxidant and antitumor advantage
in obese individuals of the Mediterranean dietary pattern
and support the role of qualiﬁed nutritionists as members
of integrated multidisciplinary teams in the complex man-
agement of obesity.
Table 9: Multiple regression analysis models (stepwise method)
with the circulating levels of Sirt4 as dependent variable to
estimate the predictive value of the following: (a) food items of
PREDIMED questionnaire and PREDIMED score and (b) total
energy intake, SFA, n-3 PUFA, vitamin C, and vitamin E.
Parameters Multiple regression analysis
Model 1 R2 β t p value
PREDIMED score 0.335 0.579 4.6 <0.001
Fruits ≥3 servings/day 0.442 0.368 2.8 0.009
Variable excluded: other items of PREDIMED score
Model 2 R2 β t p value
n-3 PUFA 0.729 0.854 10.5 <0.001
Vitamin E 0.835 0.461 5.1 <0.001
Vitamin C 0.851 0.241 2.0 0.048
Variable excluded: total energy and SFA
Among adherence to the MD and food items (model 1) and among dietary
macronutrient and micronutrient intake (model 2), circulating levels of
Sirt4 were well predicted by PREDIMED score and n-3 PUFA. A p value
in bold type denotes a signiﬁcant diﬀerence (p < 0 05). Sirt4: sirtuin 4;
PREDIMED: PREvención con DIeta MEDiterránea; SFA: saturated fatty
acids; PUFA: polyunsaturated fatty acids.
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Figure 2: Box plot of value of the ordinal predictors between
PREDIMED score and circulating levels of Sirt4. Based on the
multiple linear regression analysis with ordinal predictors, the
most signiﬁcant (α = 0 05) threshold value of the PREDIMED
score predicting the lowest decrease in circulating levels of Sirt4
was found at a score of 6 (∗p < 0 001). Sirt4: sirtuin 4;
PREDIMED: PREvención con DIeta MEDiterránea.
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